Ramm Pharma (TSE:RAMM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Ramm Pharma Corp. has announced that the Ontario Superior Court of Justice has dismissed both the CAD 3,139,931.30 claim against them and their CAD 14,220,000 counterclaim in a legal dispute with Sergio Martines and Naturale Science Inc. The court did award a minor sum for unpaid expenses to Martines. Ramm continues its operations in cannabinoid pharmacology with a diversified portfolio in various international markets.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue